APA (7th ed.) Citation

Z, Z., PK, V., JM, S., T, T., & M, F. (2020). NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. Pharmaceuticals (Basel, Switzerland), 14(1), . https://doi.org/10.3390/ph14010023

Chicago Style (17th ed.) Citation

Z, Zhai, Vaddi PK, Samson JM, Takegami T, and Fujita M. "NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma." Pharmaceuticals (Basel, Switzerland) 14, no. 1 (2020). https://doi.org/10.3390/ph14010023.

MLA (9th ed.) Citation

Z, Zhai, et al. "NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma." Pharmaceuticals (Basel, Switzerland), vol. 14, no. 1, 2020, https://doi.org/10.3390/ph14010023.